HA versus biostimulatory fillers for facial contouring

Not all dermal fillers work the same way, and for facial contouring the most consequential distinction is not between brands but between two mechanisms: hyaluronic acid gels that add volume directly, and biostimulatory products that provoke your own collagen production over months.

Hyaluronic acid: immediate, adjustable, reversible. HA fillers are gels of a sugar molecule the skin already contains. Placed along the jaw, cheek, or chin, they create contour the moment they are injected, and different formulations are engineered firmer or softer depending on whether they need to mimic bone-like structure or soft tissue. Their defining advantage is the exit: an enzyme called hyaluronidase can dissolve HA filler within days if the result is wrong or, rarely, if a vessel is compromised. That reversibility is why this publication has consistently described HA as the forgiving entry point to injectable contouring. Longevity varies by product and placement, commonly a year or more in structural areas.

Biostimulatory fillers: slower, subtler, and one-way. Calcium hydroxylapatite (sold as Radiesse) and poly-L-lactic acid (Sculptra) work differently. CaHA carries some immediate volume and then stimulates collagen as the gel carrier is absorbed; PLLA provides little instant correction at all, instead triggering gradual collagen growth across a series of sessions, with results that build over months and can last two years or more. The appeal is a result made increasingly of your own tissue. The trade-off is control: neither product can be dissolved. If a biostimulatory filler is overplaced or forms a nodule, options are limited to time, steroids, or in stubborn cases excision, which is why conservative dosing and injector experience matter even more here than with HA.

How injectors actually choose. In practice many contouring plans mix mechanisms: a firm HA or CaHA for the jawline's structural line, softer HA where tissue moves, PLLA for broad, diffuse volume loss rather than sharp definition. Age and tissue quality matter too, since biostimulation depends on the skin's capacity to make collagen, and skin quality shapes how any filler reads from the surface. A first-time patient exploring definition is usually better served starting reversible; a patient with established, stable goals may value the durability of stimulation.

The honest framing. HA buys precision and an undo button; biostimulatory fillers buy gradual, longer-lived volume at the cost of reversibility. Neither is the better filler in the abstract, and a provider who asks about your goals, timeline, and appetite for permanence before naming a product, the habit this publication looks for in any contouring provider, is applying exactly the judgment this choice requires.

Related reading: Fat transfer for facial volume and contour.